ABB  Vol.3 No.7 A , November 2012
The initial phase of oxidative stress in a steroid-induced osteonecrosis rabbit model
Abstract: Using a rabbit model, we examined N epsilon-(hexanoyl) lysine (HEL) levels in bone and urine to detect when peroxidative reaction first occurs after steroid administration. Japanese white rabbits weighing about 3.5 kg each were injected with a single intramuscular dose of methylprednisolone 40 mg/kg and divided into groups consisting of 10 rabbits each, which were killed after 1, 3, 5 and 14 days (groups A, B, C and D respectively). As a control, 10 untreated rabbits (group N) were also studied. The proximal femurs were examined histopathologically and immunohistochemically using monoclonal antibody HEL, which is a highly specific antibody against N epsilon-(hexanoyl) lysine, an early peroxidation marker. In addition, urinary levels of HEL were measured by enzyme-linked immunosorbent assay in group N, A, B and C. Osteonecrosis was detected only in group D (90%). Increase of positive reaction of HEL in the bone was observed in group A and D. HEL expression in group D was judged to be a secondary reaction resulting from the development of osteonecrosis. Urinary level of HEL showed a significant increase in only group A (P < 0.001). The present findings suggest that peroxidation in bone occurred within 24 hours after steroid administration in a rabbit model and that it is possible to noninvasively grasp the timing of this peroxidative reaction by measuring the urinary level of HEL.
Cite this paper: Ichiseki, T. , Kaneuji, A. , Ueda, Y. , Kaneko, S. , Ueda, S. and Matsumoto, T. (2012) The initial phase of oxidative stress in a steroid-induced osteonecrosis rabbit model. Advances in Bioscience and Biotechnology, 3, 978-982. doi: 10.4236/abb.2012.327120.

[1]   Baynes, J.W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes, 40, 405- 412. doi:10.2337/diabetes.40.4.405

[2]   Stocker, R. and Keaney, J.F. Jr. (2004) Role of oxidative modifications in atherosclerosis. Physiological Reviews, 84, 1381-1478. doi:10.1152/physrev.00047.2003

[3]   Ichiseki, T. Matsumoto, T. Nishino, M., Kaneuji, A. and Katsuda, S. (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. Journal of Orthopaedic Science, 9, 509-515. doi:10.1007/s00776-004-0816-1

[4]   Ichiseki, T., Kaneuji, A., Katsuda, S., Ueda, Y., Sugimori, T. and Matsumoto, T. (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford), 44, 456-460. doi:10.1093/rheumatology/keh518

[5]   Murata, M., Kumagai, K., Miyata, N., Osaki, M. and Shindo, H. (2007) Osteonecrosis in stroke-prone spontaneously hypertensive rats: Effect of glucocorticoid. Journal of Orthopaedic Science, 12, 289-295. doi:10.1007/s00776-007-1129-y

[6]   Kato, Y., Mori, Y., Makino, Y., Morimitsu, Y., Hiroi, S., Ishikawa, T. and Osawa T. (1999) Formation of Nε-(hexanonyl) lysine in protein exposed to lipid hydroperoxide. The Journal of Biological Chemistry, 274, 20406-20414. doi:10.1074/jbc.274.29.20406

[7]   Kato, Y., Miyake, Y., Yamamoto, K., Shimomura, Y., Ochi, H., Mori, Y. and Osawa, T. (2000) Preparation of a monoclonal antibody to N(epsilon)-(Hexanonyl)lysine: Application to the evaluation of protective effects of flavonoid supplementation against exercise-induced oxidative stress in rat skeletal muscle. Biochemical and Biophysical Research Communications, 274, 389-393. doi:10.1006/bbrc.2000.3150

[8]   Tokuda, F., Sando, Y., Matsui, H. and Yokoyama, T. (2009) N epsilon-(hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea. The American Journal of the Medical Sciences, 338, 127-133. doi:10.1097/MAJ.0b013e3181a478e5

[9]   Ueno, Y., Horio, F., Uchida, K., Naito, M., Nomura, H., Kato, Y., Tsuda, T., Toyokuni, S. and Osawa, T. (2002) Increase in oxidative stress in kidneys of diabetic Akita mice. Bioscience, Biotechnology, and Biochemistry, 66, 869-872. doi:10.1271/bbb.66.869

[10]   Yamamoto, T., Irisa, T., Sugioka, Y. and Sueishi, K. (1997) Effects of pulse methylprednisolone on bone and marrow tissues: Corticosteroid-induced osteonecrosis in rabbits. Arthritis & Rheumatism, 40, 2055. doi:10.1002/art.1780401119

[11]   Ichiseki, T., Ueda, Y., Katsuda, S., Kitamura, K., Kaneuji, A. and Matsumoto, T. (2006) Oxidative stress by glutathione depletion induces osteonecrosis in rats. Rheumatology (Oxford), 45, 287-290. doi:10.1093/rheumatology/kei149

[12]   Ichiseki, T., Kaneuji, A., Ueda, Y., Nakagawa, S., Mikami, T., Fukui, K. and Matsumoto, T. (2011) Osteonecrosis development in a novel rat model characterized by a single application of oxidative stress. Arthritis & Rheumatism, 63, 2138-2141. doi:10.1002/art.30365

[13]   Nishida, K., Yamamoto, T., Motomura, G., Jingushi, S. and Iwamoto, Y. (2008) Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: A preliminary histological study. Clinical Orthopaedics and Related Research, 466, 1054-1058. doi:10.1007/s11999-008-0189-4

[14]   Mikami, T., Ichiseki, T., Kaneuji, A., Ueda, Y., Sugimori, T., Fukui, K. and Matsumoto, T. (2010) Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. Journal of Orthopaedic Science, 15, 674-677. doi:10.1007/s00776-010-1516-7